NIH-funded research U01 cooperative agreement

Multi-omics approach to classifying chronic kidney disease

Official title: Multi-Omics for Chronic Kidney Disease

Funded at Columbia University Health Sciences · NIH-11416290 · Data updated 2026-11-12

A large study using genetic, epigenetic, RNA, protein, and metabolite data from people with and without CKD to better define subtypes and guide personalized care.

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionColumbia University Health Sciences
NIH-funded
Lab location1 site (New York, United States)
Project startSeptember 12, 2023
Project endMay 31, 2028
Funding year2026
Award (this year)$757,992
NIH project number5U01HG013201-04
Project IDNIH-11416290 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are adults with non-diabetic CKD and adults without CKD who are willing to provide blood and urine samples for multi-omics analyses.

Less likely to help

Patients without CKD or those unwilling to provide biological samples may not directly benefit.

What this research studies

This project aims to collect and analyze blood and urine samples from 200 people with CKD and 100 without CKD over time, applying multiple high-tech 'omics' methods. By integrating genetic, epigenetic, transcriptomic, proteomic, and metabolomic data, researchers hope to identify molecular subtypes of non-diabetic CKD. The goal is to move beyond traditional diagnosis based on kidney function to a molecular-based classification that could inform tailored treatments. The study will be conducted at Columbia University and involves a Disease Study Site dedicated to CKD within the Multi-omics Health and Disease Consortium.

Why it matters

Potential benefit: If successful, patients could receive more precise diagnoses and personalized treatment options for CKD based on their molecular profile.

How similar studies have gone: Prior multi-omics efforts have shown promise in characterizing disease heterogeneity, with growing interest in CKD-specific molecular subtypes.

Where this research is happening

  • Columbia University Health Sciences
    New York, United States
    Active

Researchers

  • Principal investigator: Kiryluk, Krzysztof — Columbia University Health Sciences
  • Study coordinator: Kiryluk, Krzysztof

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.